Evidence map›Paper›PMID 36123260›Full record

ArticleVaccine2022

The connection between COVID-19 vaccine abundance, vaccination coverage, and public trust in government across the globe.

Ida G Monfared

Abstract read
In one paragraph

Article in Vaccine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ida G MonfaredGeorg-August-University of Göttingen, Department of Economics, Centre for Modern Indian Studies, Waldweg 26, 37073 Göttingen, Germany. Electronic address: ida.gohardoustmonfared@uni-goettingen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates that how the number of COVID-19 vaccines secured correlates with the vaccination coverage (full and booster) depending on whether or not there is trust in national government across 47 countries. The data are based on global figures as of Nov. 2021 and Feb. 2022 while measures for confidence in government is according to Gallup World Poll, Oct. 2021. The model includes an interaction term of these two predictors, also controls for a range of socio-economic factors and country specific variables. The results indicate a non-linear and mixed relationship between the numbers secured, the public trust, and the vaccination rate. In Feb. 2022, with confidence in government, securing number of vaccines to cover 200% of the population (or more) increased the full vaccination rate by 12.26% (95% CI: 11.70-12.81); where number secured was 300% (or more), the coverage increased by 7.46% (95% CI: 6.95-7.97). Under similar scenarios, rate of booster shots increased by 13.16% (95% CI: 12.62-13.70; p < 0.01) and 14.36% (95% CI: 13.86-14.85; p < 0.01), respectively. Where the number secured fell below 200%, confidence in government had a revers relationship with the rate of full vaccination (-2.65; 95% CI: -3.32 to -1.99), yet positive with the rate of booster shots (1.65; 95% CI: 1.18-2.12). These results indicate that better success can be achieved by a combination of factors including securing sufficient number of vaccines as well as improving the public trust. Vaccine abundance, however, cannot be translated into greater success in vaccination coverage. This study highlights the importance of efficiency in acquiring vaccine resources and need for improvement in public belief in immunization programmes rather than stock piling.

Indexed as

COVID-19VaccinesCOVID-19 VaccinesGovernmentHumansTrustVaccinationVaccination CoverageCOVID-19 VaccinesVaccinesCOVID-19 vaccineEfficiencyGlobal coverageProcurementPublic trust

Identifiers

PMID36123260
PMCPMC9477190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.